House Bill No. introduced by S. Rosenzweig and J. Gillette mandates that group health insurance for state employees, including those in the Montana University System, must cover specific treatments and medications for Class 3 obesity and polycystic ovary syndrome. The bill requires insurance contracts to include coverage for glucagon-like peptide-1 receptor agonists when deemed medically necessary, while allowing for standard deductibles, coinsurance, and copayment provisions. However, it prohibits any special limitations on the coverage of these medications. Additionally, the bill establishes reporting requirements for the Department of Administration to evaluate the effectiveness and budget implications of this coverage.

The bill also amends existing laws related to health maintenance organizations (HMOs) and self-funded multiple employer welfare arrangements, clarifying that HMOs are not exempt from certain regulations and must comply with communication and quality assurance standards. It appropriates $1.5 million from the state general fund for each fiscal year of the biennium starting July 1, 2025, to support the implementation of these mandates. The previous references to diabetes have been removed, and the new provisions will be codified into Title 2, Chapter 18, Part 7 of the law, ensuring that the updated regulations are clearly defined within the legal framework.

Statutes affected:
LC Text: 2-18-704, 33-31-111, 33-35-306
HB0783_1(1): 2-18-704, 33-31-111, 33-35-306
HB0783_1(2): 2-18-704, 33-31-111, 33-35-306
HB0783_1(3): 2-18-704, 33-31-111, 33-35-306
HB0783_1(4): 2-18-704, 33-31-111, 33-35-306
HB0783_1(5): 2-18-704, 33-31-111, 33-35-306
HB0783_1: 2-18-704, 33-31-111, 33-35-306
HB0783_2(1): 2-18-704, 33-31-111, 33-35-306
HB0783_2(10): 2-18-704, 33-31-111, 33-35-306
HB0783_2(11): 2-18-704, 33-31-111, 33-35-306
HB0783_2(12): 2-18-704, 33-31-111, 33-35-306
HB0783_2(2): 2-18-704, 33-31-111, 33-35-306
HB0783_2(3): 2-18-704, 33-31-111, 33-35-306
HB0783_2(4): 2-18-704, 33-31-111, 33-35-306
HB0783_2(5): 2-18-704, 33-31-111, 33-35-306
HB0783_2(6): 2-18-704, 33-31-111, 33-35-306
HB0783_2(7): 2-18-704, 33-31-111, 33-35-306
HB0783_2(8): 2-18-704, 33-31-111, 33-35-306
HB0783_2(9): 2-18-704, 33-31-111, 33-35-306
HB0783_2: 2-18-704, 33-31-111, 33-35-306
HB0783_3(1): 2-18-704, 33-31-111, 33-35-306
HB0783_3(10): 2-18-704, 33-31-111, 33-35-306
HB0783_3(11): 2-18-704, 33-31-111, 33-35-306
HB0783_3(12): 2-18-704, 33-31-111, 33-35-306
HB0783_3(2): 2-18-704, 33-31-111, 33-35-306
HB0783_3(3): 2-18-704, 33-31-111, 33-35-306
HB0783_3(4): 2-18-704, 33-31-111, 33-35-306
HB0783_3(5): 2-18-704, 33-31-111, 33-35-306
HB0783_3(6): 2-18-704, 33-31-111, 33-35-306
HB0783_3(7): 2-18-704, 33-31-111, 33-35-306
HB0783_3(8): 2-18-704, 33-31-111, 33-35-306
HB0783_3(9): 2-18-704, 33-31-111, 33-35-306
HB0783_3: 2-18-704, 33-31-111, 33-35-306